Microbiological recommendations for the diagnosis and follow-up of infective endocarditis  by Gutschik, Ernö
Microbiological recommendations for the diagnosis 
and follow-up of infective endocarditis 
Clin Microhiol htfect 1998; 4: 3S10-3S16 
Ern0 Gutschik and the Endocarditis Working Group of the International Society for 
C h  e rn o therapy * 
Department of Clinical Microbiology, Bispebjerg Hospital, Copenhagen Hospital Corporation, 
University of Copenhagen, Denmark 
These recornmendations are based on appreciation of 
new knowledge of the pathogenesis of the disease 
gained by endocarditis research, basic principles of 
collection of clinical specimens for laboratory testing, 
estimation of the number of cultures needed for diag- 
nosis and control of antimicrobial treatment, handling 
of clinical specimens in the microbiological laboratory 
and the principles of antimicrobial susceptibility testing 
of the microbial isolates. 
Considering culture-dependent and culture-inde- 
pendent methods, a large number of conventional 
systems, media, etc. have been described in an effort to 
increase the speed and sensitivity of microbial detection 
and have been the subject of numerous, sometimes 
conflicting, studies. An evaluation of these methods, 
media, etc. is outside of the scope of this overview. 
The recommendations presented here describe the 
most significant and generally accepted procedures 
which Fhould be considered in every case of infective 
endocarditis. 
BLOOD CULTURES 
Collection of blood for culture 
Early studies demonstrated that the bacteremia of 
endocarditis is often continuous. There is no significant 
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advantage to obtaining blood cultures at any particular 
body temperature. Furthermore, there is no significant 
advantage of arterial over venous blood [I] .  
The number of blood cultures and the timing 
and volume of blood collection are important variables 
(Table 1). In order to obtain a reliable high detection 
rate of positive blood cultures, to demonstrate the 
continuous nature of septicemia and to ensure the 
possibility of discrimination between ‘endocarditis 
strains’ and contaniiriants, it is recoirirnended to draw 
20 mL blood in each of three separate samplings from 
adults over 1-24 h [2]. Cultures should riot be taken 
through indwelling vascular catheters because of the 
risk of contaminants, 
I n  a recent study of the clinical significance of 
positive blood cultures [3] ,  41.5% of the isolates were 
judged to represent coiitaniination and another 5.3% 
were of indeterminate clinical significance. Generally, 
81 .Y% of coagulase-negative staphylococci, and 49.3% 
of viridans streptococci were indicated as contaminants. 
This study demonstrates that contaniination in blood 
cultures is more frequent in the 1990s than it was two 
decades ago. The reason for this, aniong other5, 
is more frequent use of intravascular and prosthetic 
devices, and probably newer blood culture systems 
and media which are more sensitive and capable of 
detecting viable skin bacteria even after appropriate 
antiseptic preparation before collection of the blood 
cultures. This observation underTcores the significance 
of three or more separate venepunctures in order to 
‘The group of experts comprised: C. Carbon, D.T. Durack, 
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Table 1 Blood cultures: collection of blood for diagnostic purposes 
~ 
Blood cultures: three or more separate venepunctures over 1-24 h and according to the clinical presentanon of the patient. Pedorm either 
two or more blood cultures separated by at least 12 h, or three or more blood cultures with at least 1 h between the first and the last culture 
At least 20 mL of blood should be drawn in each sampling from adults 
It is recommended to utilize a pyridoxal-enriched medium. Two or three additional blood cultures are recommended a t  48 h in cases with 
negative initial blood culture results and a high degree of clinical suspicion of Infective endocarditis 
demonstrate the continuous seeding of blood from the 
infected heart valve, and to discriminate between true 
pathogens and contaminants (Table 1). 
The rate of positive culture may be influenced by 
the type of microorganism involved. Generally, the 
bacteremias are low-grade, half of the bacteremic 
patients having less than one organism per mL blood 
[4]. In addition, endocarditis may also be caused by 
microorganisms which are difficult to culture using 
routine techniques. To maximize the detection of 
nutritionally deficient streptococci, it is recommended 
to utilize pyridoxal-enriched medium [5]. 
Special diagnostic measures should be taken in the 
case of negative initial blood culture results (Table 1). If 
the patient received prior antibiotic therapy. it is worth 
obtaining serial blood cultures off antibiotic therapy. 
If antibiotics are only given 2-3 days prior to their 
discontinuation, blood cultures will probably become 
rapidly positive 161. In cases where there is a high 
degree of clinical suspicion of endocarditis, especially 
for Staphylococcus aureus, fungemia or anaerobic bacteria, 
the use of a lysis-centrifugation system should be 
considered [7,8]. 
Handling of blood cultures in the clinical microbiological 
laboratory 
Conventional cultures (vented or unvented) are usually 
incubated at  35-37°C in 5-10% COz and checked 
daily for visible growth (Table 2). Routine Gram- 
staining of negative cultures will rarely detect positive 
cultures because the sensitivity of Gram stains is only 
slightly better than that of macroscopic examination 
[4] and, in addition, an opening (or needle perforation) 
of the bottles will facilitate possible laboratory con- 
tamination. Terminal blind subculture after 7 days is 
recommended by some centers [4]. 
Murray [9] investigated the value of incubating 
blood culture broths for more than 7 days, using 20 000 
blood cultures from a tertiary-care hospital. He found 
that, although incubation of blood culture bottles for 
7 days will not detect some fastidious bacteria and 
fungi, routine incubation for a longer period is not 
justified. 
In cases where there is a strong index of suspicion 
for infective endocarditis in spite of negative cul- 
ture results, communication between the microbiology 
laboratory and the clinical staff is vital for making 
decisions regarding further incubation and, perhaps, 
specific measures concerning methods and media 
for detection of fastidious Gram-negative rods, such 
as in the HACEK (Haemophilus, Actinobacilltrs, Cardio- 
bacterium, Eikenella, Kingella) group, nutritionally 
deficient streptococci, bacterial L-forms (cell wall- 
deficient bacteria), Brucella spp., Neisseria spp., Legionella 
spp., mycobacteria, nocarda, rickettsial species, Bartonella 
spp., Chlamydia spp. and fungi [lo]. The incubation 
period of 14 days for such a situation is arbitrarily 
chosen by the Working Group (Table 2) but will 
probably represent an optimal time period for detection 
of the fastidious microorganisms [2,4]. 
Cultures during and after therapy 
Within several days of initiation of appropriate anti- 
microbial therapy, bacteremia resolves and there is 
no need for additional blood cultures. In one large 
prospective trial of Staphylococcus aureus endocarditis, 
blood was cultured daily for the first 7 days of treat- 
ment and weekly thereafter. The mean duration of 
bacterernia in non-addicts was 2.8 k1.4 days for nafcihn 
plus gentamicin, and 4.1k1.4 days for nafcillin. The 
clinical response was rapid and the patients were febrile 
for approximately the same amount of time [ 111. Thus, 
Table 2 Blood cultures: handling of blood cultures in the clinical microbiology laboratory 
Blood cultures should be checked for growth for a minimum of 5 days, with daily examination and a further examination on day 7 
[n cases where there is a strong index of suspicion, the cultures should be incubated until, and retested on, day 14 before being reported as 
sterile 
No special recommendation exists for blood cultures obtained from patients with prosthetic valves. 
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unchanged febrile illness beyond the first week of 
treatment warrants a reassessment of the antibiotic 
prescription [l 11. Additional blood cultures are recon- 
mended in these cases (Table 3), with special attention 
given to metastatic lesions or valve ring abscesses. This 
is uiicommon with pathogens of low virulence such as 
viridans streptococci, coagulase-negative staphylococci 
or other highly antibiotic-sensitive organisms, but occurs 
more often during treatment for Staphylococcus aureus 
endocarditis. Septicemia and, on occasion, valvular 
superinfection with bacteria resistant to antibiotic 
treatment or Candida spp. as a complication of the use 
of intravascular catheters should also be considered. 
Negative blood cultures, on the other hand, do not 
support a claim of bacteriologic cure of infective 
endocarditis, and thus no monitoring of efficacy is 
recommended (Table 3).  
Follow-up cultures just after standard therapy and 
good clinical response are not recommended. In most 
relapses, renewed symptoms, signs of infection and 
bacteremia appear 2-4 weeks after completion of 
therapy [ 121. Thus, follow-up cultures are only recom- 
mended when there are signs of relapse. 
IDENTIFICATION OF MICROORGANISMS 
‘Typical inicroorganismr’ comprise one of the major 
Duke criteria [ 131. Thus, speciation of microorganisms 
is necessary for diagnostic purposes. Typical organisms 
are viridans streptococci, Streptococcus bovis, and the 
HACEK group of fastidious Gram-negative organisms. 
Speciation of streptococci (and other genera) is 
useful too, because within the viridans group, and 
streptococci in general, important differences in the 
propensity to cause endocarditis have been noted [ 141. 
The same consideration seems to be valid for coagulase- 
negative staphylococci. Indeed, positive blood cultures 
yielding coagulase-positive staphylococci may present 
great interpretative difficulties, even when more than 
one culture set is positive (Table 1). The same biotype 
and the same antibiogram do not necessarily represent 
a true pathogen 131. In certain circumstances, such as 
prosthetic valve endocarditis, molecular typing tech- 
niques are recommended to confirm the identity of the 
isolates (Table 4). 
Furthermore, speciation is necessary for epidemio- 
logic purposes, and it is mandatory to diagnose 
recurrences (Table 4). Recent efforts to provide a 
simple diagnostic testing system have allowed most 
laboratories to speciate these organisms, but speciation 
or further taxonomic positioning can be done by 
reference laboratories. It is important to store all endo- 
carditis isolates in order to recognize relapses. Isolates 
should be kept refrigerated at  - 8 O O C  for 1 year or 
more. 
Speciation of the isolates early in the diagnostic 
procedure can be necessary to establish the validity 
of the antibiotic susceptibility pattern and to decide 
the type of antibiotic for antimicrobial monotherapy or 
combination therapy. Among enterococci, the differen- 
Table 3 Blood cultures: cultures during a n d  after therapy 
Not  recommended in cases with a good clinical response 
I n  cascs \vith no chnical response or delayed response beyond what is cspcctcd for the initial d a t e s ,  additional blood cultures may he useful 
.ind shonld be obtained at the time correFponding to trough antibiotic Ievek 
No monitoring of efficacy (therapcutic ‘window’) i~ reconmiendcd 
Follow-up culture\: 
After standard therapy, and in the absence of symptoms, blood cultures are not rccomrnended. I’hysicians, hoxvever, Fhould be alert to 
early signs of relapse 
Table 4 Identification of microorganisms 
Speciation of the nucroorga~iism IS necessary for epidemiologic purposes and to adequately interpret the portal of entry and possible recurrences 
I t  IF  rcconiiiiendcd that blood strains isolatcd from patients with endocarditis should he stored in order to recognize relapse5 
Identical Fpccics dcsignations (biotypes and aiitibiograrns) should be demonstrated for coagulase-negative staphylococci, and, in special 
CirciimFtance?, molecular typing technique? \hould be used to confirm the identity of the iwlate\ 
Speciation chould also be pertbrnied in order to establish the antibiotic ~usceptibility pattern of the pathogen and for specific xiditional 
iiivrstigatioiis o f  associated diseases 
The viridans streptococci h u l d  be differentiated froin Strcptmo( tw 6oi.b 
Among the entemcocci, dif~ermtiatioii of E,lrerotorrtrrs.~l;lrculis and B r f r r u ~ o c t u ~ ~ f ; ~ e c i ~ l , n  is nccrasary 
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tiation between Enterococcusfaecalis and Enterococcusfaecium 
is mandatory for selection of a synergistic p-lactam- 
aininoglycoside regimen. It is important to notice that 
Enterococcus faecium strains resist synergistic killing by 
penicillin in combination with kanamycin, tobramycin 
and netilmicin even in the absence of high-level 
resistance to these agents [15]. 
Streptococcus bovis should be differentiated from 
other streptococci (Table 4) because adults with these 
bacteremic isolates have a significant incidence of 
underlying gastrointestinal neoplasm [16,17]. The 
consequence of this diagnosis should be that all patients 
with Streptococcus bovis bacteremia with or without 
endocarditis must undergo diagnostic studies, including 
cdonoscopy, to rule out an occult colonic malignancy, 
and, if the initial study is negative, tests should be 
repeated 6 months later. 
ANTlMlCROBlAL SUSCEPTIBILITY TESTING 
Recommendation for standardized sensitivity tests 
Optimal therapy of infective endocarditis requires 
bactericidal antimicrobial agents. The most reliable 
bactericidal agents include: penicillins, cephalosporins, 
aminoglycosides, fluoroquinolones and rifampicin. In 
some cases, combination therapy is needed for enhance- 
ment of bacterial activity. For fungal endocarditis there 
is no routine, standardized sensitivity test available. 
Minimal inhibitory concentration (MIC) deter- 
mination is preferred for susceptibility testing. The 
MIC is a prerequisite for demonstrating full sensitivity 
of viridans streptococci to penicillin or testing entero- 
cocci for high-level resistance to aminoglycosides (Table 
5). Disk testing will suffice in most cases as an initial 
testing procedure in uncomplicated cases, when full 
sensitivity is demonstrated for the drug usually 
preferred for treatment. The method of disk sensitivity 
testing is not uniform between different laboratories. 
However, the sensitivity (breakpoint) is usually set at 
one-sixteenth to one-fourth of the peak levels of drug 
available in serum [18]. Since MICs of the organisms 
are usually far below this point, disk susceptibility 
testing is acceptable as the (initial) key to choosing 
an appropriate antimicrobial dosing regimen. MIC 
susceptibility testing should be carried out as soon as 
possible for relevant antibiotics in order to re-evaluate 
the therapeutic regimen. 
A simple diagnostic test system for p-lactamase 
production is available in most laboratories, e.g. the 
nitrocefin test [19]. Routine testing for p-lactamase 
production for all of the HACEK group of isolates is 
recommended (Table 5). 
Additional sensitivity tests 
Disk testing and MIC determination measure only the 
inhibitory activity of the agents. It seems logical to have 
additional laboratory methods that assess the bacteri- 
cidal activity of the antimicrobial agents. Minimal 
bactericidal concentrations (MBCs), which are the 
concentrations needed to kill the majority of viable 
microorganisms under a given set of conditions, can be 
used to define tolerance. 
Tolerance is the situation in which a particular 
organism shows a substantial difference (32-fold or 
more) between the MIC and MBC for an antibiotic 
which is normally bactericidal. However, a number of 
technical factors can have a significant effect upon the 
outcome and the reproducibility of bactericidal testing 
[20]. Although tolerance is described for staphylococcal 
and for streptococcal strains and the significance of this 
phenomenon has been shown in the animal models of 
endocarditis [21-231, tolerance has not been shown to 
result in decreased cure rates in humans. Thus, MBC 
is not routinely recommended by the Working Group 
(Table 6). Killing curves constitute an excellent method 
to test the ef3icacy of conibinations of drugs, and for 
evaluation of synergy and antagonism. This method is, 
however, time-consuming and not recommended. 
The serum inhibitory test (SIT) and serum bacteri- 
cidal test (SBT) measure the inhibitory capacity or 
the bactericidal activity of blood during antimicrobial 
treatment of endocarditis. These tests are subject to 
Table 5 Antimicrobial susceptibility testing: recommendation of standardized sensitivity tests 
Determination of MIC is recommended when available, but disk testing will suffice in most cases as an initial test procedure 
MIC determinations for penicillin and in some cases vancomycin, teicoplanin, aminoglycoside antibiotics and quinolones are necessary for 
thc choice of therapeutic regimen 
Staphylococci: test for methicillin resistance 
Viridans streptococci: demonstrate full sensitivity to penicillin 
HACEK: test for P-lactamase production 
Enterococci: test for high-level resistance to streptomycin (22000 mg/L) and gentamicm (2500 mg/L). Routine susceptibility testing should 
include glycopeptide antibiotics for Grain-positive organisms 
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the same problems as MBC, and their usefulness is 
hampered by lack of standardization. SIT and SBT 
titers cannot be expected to predict anything that 
wrum levels and/or MBCs or MICs cannot predict 
I201. 
MICROBIOLOGICAL DIAGNOSIS O N  VEGETATIONS, 
VALVES, EMBOLI, FOREIGN MATERIAL 
The definitive proof of infective endocarditis is demon- 
stration of bacteria in the endocardia1 vegetations. It 
is therefore mandatory that valves and vegetations 
removed at cardiac surgery are transported immediately 
to the clinical microbiological laboratory for culturing 
and for direct microscopy. Histologic investigation 
ir  also recommended. Other relevant materials (Table 
7) should be processed in the same way. 
During antibiotic treatment, the culture positivity 
of vegetations will fall to 64% during the first week of 
‘standard antinlicrobial therapy’ and to 21% after two 
weeks’ of therapy. No positive culture was found after 
3 weeks’ of therapy [24]. The Gram stain ofvegetations 
will show bacteria in 64-7596 of all cases during 4-6 
weeks of antimicrobial treatment and in 27% of cases 
1-6 months after the end of standard-duration anti- 
microbial therapy [24]. Thus, a positive Gram stain 
or acridine orange stain do not necessarily indicate 
antibiotic failure. 
SEROLOGY, BIOTECHNOLOGY 
Unusual causes of infective endocarditis niay present 
difficulties in diagnosis; thus the group responsible for 
‘culture-negative’ endocarditis probably consists of many 
of these organisms (Table 8). Most of these will grow 
poorly in culture, or culture may take weeks to show 
evidence of growth [25]. An example is endocarditis 
caused by Bartonella quintana. The organism was cultured 
28 and 42 days after incubation in BACTEC 26 bottles 
[26]. Methods for the microbiological diagnosis have 
been recently discussed [27]. 
Diagnostic procedures for infective endocarditis 
due to these unusual microorganisms include specific 
substrates for culture, cell lines for incubation and 
culture, different serologic methods, immunofluo- 
rescent techniques and polymerase chain reaction (PCR) 
(Table 8). 
Continuous bacteremia is a characteristic feature of 
endocarditis bacteremia. The antibody response of the 
offending bacteria is pronounced early in the course of 
endocarditis and could be used for diagnostic purposes. 
However, a wide range of antibody specificities in 
normal sera have forced most investigators to use an 
increase in antibody titer to discriminate between 
different groups of patients with and without endo- 
carditis. Direct antigen detection, as in the case of 
Staplzylococcirr aureus endocarditis, was unsuccessful due 
to low sensitivity, probably because of the binding 
of the antigen in immune complexes [28]. Crossed 
immunoelectrophoresis has been successful in finding 
cases of bacterial endocarditis caused by viridans 
streptococci [29] but these techniques are still not 
reliable enough for routine use. 
CONCLUDING REMARKS 
Today, infective endocarditis is a curable disease, but 
appropriate treatment requires the cooperation of a 
team of specialists. The role of the clinical microbio- 
logical laboratory is to demonstrate and characterize 
Table 6 Antimicrobial susceptibility testing: additional sensitivity tests 
MBC: not routinely recommended 
Killing curves: not routinely recommended. Howcvcr, in relapses, the use of unusual antibiotic combindtions, new antibiotic5 for research, 
CtC. .  15 Justified 
Scrum bactericidal test: not routinely recommended 
Serum inhibitory test: not routinely recommended. Its use in therapy fallures, relapses and unusual therapeutic regimens is stdl being debated 
Table 7 Diagnosis on vegetations, valves, emboli, foreign material, etc. 
Specimens should be d x m t t e d  for Grain stain, culture and histopathologic investigations 
Thc prescncc of Grm-positive cocci on miear only does not mdicate fiilure of therapy 
Molecular biological techniques are recommended when unusual organisms are susprcted (see Table 8) 
For foreign material, including valves, electrodes, patches, wtures, teflon platec, etc., culture should be performed in addition to Gram stain 
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Table 8 Microbiological diagnosis: serology, biotechnology 
In cases of initial negative blood cultures, and according to the clinical setting, specific laboratory investigations are recommended for the 
following microorganisms: 
Legionella spp. (in special media, and appropriate serologic tests) 
Coxielia burnetii (in special cell cultures, use of P C R  and serologic tests) 
Chlamydia spp. (in McCoy cell or other appropriate cell cultures, use of P C R  and serologic tests) 
M ~ C O ~ ~ Q S ~ ~ I Q  spp. (in special media, and serologic tests) 
Mycobacterium spp. (in special media, or PCR) 
Bartonella spp. and Afipia spp. (in AIDS patient) (PCR and immunofluorescence). Be aware of cross-reactions with Chlamydia pneumoniae 
Fungi (routine serology is only available in some reference laboratories) (diagnosis is usually made on  the basis of clinical findings, 
continuous positive blood cultures, history of emboli and characteristic echocardiographic patterns) 
N o  routine serology exists for streptococci and staphylococci 
the infective organism, and to recommend antibiotic 
treatment based on laboratory susceptibility testing. 
The microbiologist should be medically qualified, 
because relevant guidance and cooperation require 
attention to the clinical situation. This is especially 
important when the performance and the inter- 
pretation of the test results are controversial. Ideally, the 
use of all microbiological methods should be tempered 
by clinical judgment in each individual case. 
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